Oncotrace RGCC Test
Oncotrace RGCC Test
What are Identified ?
CTC’s & CSC’s (Circulating Tumour Cells and Cancer Stem Cells)
Test Results
21 days *
Test Type
Follow up Test
Test Frequency
Quarterly
Sample Required
Blood sample
Cancer Type
All type of CancersBlood Sample Qty
15 ml peripheral whole bloodSample Test Report
DESCRIPTION
Oncotrace RGCC predicts the primary tumour in case of unknown primary origin. It also provides information about the presence of circulating tumour cells, their concentration, and the immunophenotype of cancer stem cell markers which can be responsible for the recurrence or relapse of cancer.
RESEARCH ARTICLES
- Flow Cytometric Detection of Circulating Tumor Cells in Breast Cancer Patients: A Blinded Study.
- A Novel Method for Colorectal Cancer Screening Based on Circulating Tumor Cells and Machine Learning.
- Recent Advances in Methods for Circulating Tumor Cell Detection.
- Clinical associations of mucin 1 in human lung cancer and precancerous lesions
- Aberrant expression of CD227 is correlated with tumor characteristics and invasiveness of breast carcinoma.
- CD63 expression in metastatic melanoma and melanocytic nevi in lymph nodes.
- Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine.
- Tracking cancer progression: from circulating tumor cells to metastasis.
- Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther.